Filing Details
- Accession Number:
- 0001818382-24-000165
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-29 18:45:12
- Reporting Period:
- 2024-08-27
- Accepted Time:
- 2024-08-29 18:45:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1818382 | Humacyte Inc. | HUMA | Biological Products, (No Disgnostic Substances) (2836) | 851763759 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1878193 | A. Dale Sander | 2525 East North Carolina Highway 54 Durham NC 27713 | Cfo And Chief Corp. Deve. Off. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-08-27 | 39,389 | $2.56 | 41,389 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-08-27 | 39,389 | $6.68 | 2,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy) | Disposition | 2024-08-27 | 39,389 | $0.00 | 39,389 | $2.56 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-09-01 | 2025-09-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 20,600 | Indirect | By spouse |
Footnotes
- The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $6.67 to $6.725. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
